Morgan Stanley’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.62M | Buy |
378,402
+197,812
| +110% | +$1.89M | ﹤0.01% | 4320 |
|
|
2025
Q1 | $1.68M | Buy |
180,590
+106,441
| +144% | +$990K | ﹤0.01% | 4715 |
|
|
2024
Q4 | $1.03M | Buy |
74,149
+5,233
| +8% | +$72.7K | ﹤0.01% | 5075 |
|
|
2024
Q3 | $1.62M | Buy |
68,916
+4,385
| +7% | +$103K | ﹤0.01% | 4769 |
|
|
2024
Q2 | $1.03M | Buy |
64,531
+29,294
| +83% | +$468K | ﹤0.01% | 4943 |
|
|
2024
Q1 | $578K | Sell |
35,237
-36,099
| -51% | -$592K | ﹤0.01% | 5243 |
|
|
2023
Q4 | $988K | Buy |
71,336
+53,052
| +290% | +$735K | ﹤0.01% | 5300 |
|
|
2023
Q3 | $252K | Sell |
18,284
-486
| -3% | -$6.69K | ﹤0.01% | 5476 |
|
|
2023
Q2 | $320K | Buy |
18,770
+3,461
| +23% | +$58.9K | ﹤0.01% | 5438 |
|
|
2023
Q1 | $246K | Buy |
15,309
+4,906
| +47% | +$78.8K | ﹤0.01% | 5612 |
|
|
2022
Q4 | $79.1K | Sell |
10,403
-2,119
| -17% | -$16.1K | ﹤0.01% | 6085 |
|
|
2022
Q3 | $110K | Sell |
12,522
-914
| -7% | -$8.03K | ﹤0.01% | 6031 |
|
|
2022
Q2 | $96K | Buy |
13,436
+11,865
| +755% | +$84.8K | ﹤0.01% | 6297 |
|
|
2022
Q1 | $16K | Sell |
1,571
-34,177
| -96% | -$348K | ﹤0.01% | 7239 |
|
|
2021
Q4 | $503K | Buy |
+35,748
| New | +$503K | ﹤0.01% | 5538 |
|